Quantitation of alpha(2)-microglobulin after administration of structurally divergent chemical compounds.
alpha(2)-Microglobulin-induced nephropathy is a phenomenon which is exclusively found in adult male rats. Various chemicals are able to bind to alpha(2)-microglobulin thus inhibiting its proteolytic degradation in lysosomes of the P2 segment of the rat nephron. The accumulation of this protein in 'protein droplets' or 'hyaline droplets' leads to necrosis, followed by regeneration which possibly later results in the formation of tumours. Here we report the development of a monoclonal antibody which is specific for alpha(2)-microglobulin. It was utilized to measure alpha(2)-microglobulin concentrations in plasma and tissues, and to stain alpha(2)-microglobulin in fixed tissue slides. In two studies we administered to adult male Wistar rats two groups of compounds: (1) one group of structurally diverse compounds, which give an overview of chemical entities capable of inducing the accumulation of alpha(2)-microglobulin; and (2) another group of structurally closely related compounds (i.e. substituted benzene derivatives) for the purpose of elucidating possible structure-activity relationships. The degree of alpha(2)-microglobulin-induced nephropathy was determined by immunohistochemical staining of kidney sections. In addition, liver and kidney tissue and plasma concentrations of alpha(2)-microglobulin were not found to be elevated whereas kidney tissue concentrations were higher than the controls. The increase over control values ranged from 154% (1,4-dichloromethyl-benzene) to 321% [alpha-methyl-4-(1-methylethyl)-cyclohexanemethanol]. Comparing structurally related benzene derivatives, the hyaline droplet accumulating (HDA) potential was found to depend both on the type of substituent and its position at the aromatic ring. In general HDA activity increased in the order benzene approximately equal to phenol approximately equal to alkylated phenols < halogenated phenols < halogenated benzenes. Further QSAR studies are needed to provide a theoretical base for these observations.
Hildebrand
H
H
Bayer AG, Toxikologie, Wuppertal, Germany.
Hartmann
E
E
Popp
A
A
Bomhard
E
E
D000510:Alpha-Globulins / Q000032:analysis* / Q000276:immunology / Q000633:toxicity; D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D000918:Antibody Specificity; D000941:Antigens / Q000737:chemistry / Q000276:immunology; D001555:Benzene Derivatives / Q000378:metabolism / Q000633:toxicity*; D001667:Binding, Competitive; D015153:Blotting, Western; D002478:Cells, Cultured; D004591:Electrophoresis, Polyacrylamide Gel; D004797:Enzyme-Linked Immunosorbent Assay; D005921:Glomerulonephritis / Q000139:chemically induced; D006433:Hemocyanins / Q000737:chemistry / Q000276:immunology; D006825:Hybridomas; D007150:Immunohistochemistry; D007668:Kidney / Q000737:chemistry* / Q000187:drug effects / Q000473:pathology; D008099:Liver / Q000737:chemistry* / Q000187:drug effects / Q000473:pathology; D008297:Male; D010636:Phenols / Q000378:metabolism / Q000633:toxicity*; D051381:Rats; D017208:Rats, Wistar; D013329:Structure-Activity Relationship
D000510:Alpha-Globulins; D000911:Antibodies, Monoclonal; D000941:Antigens; D001555:Benzene Derivatives; D010636:Phenols; C025500:alpha(2)-microglobulin; D006433:Hemocyanins; C032808:keyhole-limpet hemocyanin